Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
BIIB.OQ - Biogen Inc
Biogen Inc Engage and Emerge Trials at CTAD Call
Nov 11, 2021 / 10:10PM GMT
=====================
Conference Call Participants
=====================
* Gil Rabinovici
* Jeffrey Cummings
* Oskar Hansson
* Stephen Salloway
=====================
Presentation
--------------------------------------------------------------------------------
Stephen Salloway, [1]
--------------------------------------------------------------------------------
Welcome, everybody, to late-breaking readout, roundtable #8. I'm Steve Salloway from Brown University. And we have an exciting program to share with you today. The title is dose and time-dependent changes in plasma p-tau181 in patients treated with aducanumab in the ENGAGE and EMERGE trials.
And we're very fortunate to have Oskar Hansson and others from outside the U.S. We lowered the immigration standard. He's back in. And thank God and to all of you, welcome back to the U.S. And so we have Oskar here from Lund University; Gil
Trustpilot
